PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 27 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,000 | +38.5% | 11,139 | +71.4% | 0.00% | – |
| Q2 2023 | $13,000 | – | 6,499 | +1642.4% | 0.00% | – |
| Q3 2022 | $0 | – | 373 | +2386.7% | 0.00% | – |
| Q2 2022 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 15 | -97.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 500 | -55.4% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 1,120 | +80.6% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 620 | +24.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 500 | -18.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 610 | -7.7% | 0.00% | – |
| Q1 2020 | $1,000 | -66.7% | 661 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | – | 661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,413,487 | $2,513,000 | 0.04% |
| CAPITAL PERFORMANCE ADVISORS LLP | 25,974 | $27,000 | 0.02% |
| MEITAV INVESTMENT HOUSE LTD | 244,332 | $256,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,790 | $139,000 | 0.00% |
| IHT Wealth Management, LLC | 22,000 | $23,000 | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
| Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,027 | $3,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| DAVENPORT & Co LLC | 22,000 | $23,000 | 0.00% |